Quantcast

Latest BioCurex Inc. Stories

2008-10-03 09:00:07

RICHMOND, BRITISH COLUMBIA--(Marketwire - Oct. 3, 2008) - BioCurex Inc. (OTCBB:BOCX) today announced results showing that its RECAF test can detect cancer with high sensitivity and specificity using a small sample of saliva. The work was done as part of an ongoing collaboration with the Goshen Center for Cancer Care in Indiana. Saliva from cancer patients and healthy donors was tested using a slightly modified RECAF chemiluminescence assay (the chemiluminescence format was chosen for...

2008-09-17 09:00:14

RICHMOND, BRITISH COLUMBIA--(Marketwire - Sept. 17, 2008) - BioCurex Inc. (OTCBB:BOCX) today announced that the Australian Patent Office has issued a notice of acceptance for a divisional application of our original patent filing. This is the first patent awarded to BioCurex for the development of therapeutic applications of its RECAF technology. All proprietary protection had previously only covered diagnostic applications, and this approval from the Australian Patent Office is a milestone...

2008-08-14 09:00:19

BioCurex Inc. (OTCBB: BOCX) today announced that the Congress Scientific Committee has accepted its presentation to the ISOBM annual meeting. BioCurex will present results obtained with its ELISA RECAF blood test for cancer at the 2008 assembly of the International Society of Oncology and Bio-Markers (ISOBM). The conference will be held from October 5th to October 9th, in Tokyo, Japan and will bring together scientists, clinicians and companies involved in the field of cancer markers. Dr....

2008-07-24 09:00:35

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 24, 2008) - BioCurex (OTCBB:BOCX) is pleased to announce it has retained the services of AGORACOM Investor Relations ("AGORACOM") (http:// www.agoracom.com) to provide online investor relations services, a Web 2.0 social network for current shareholders and Tier-1 awareness through the world's biggest websites for the purpose of attracting new shareholders. ONLINE INVESTOR RELATIONS MAXIMIZES SPEED, TRANSPARENCY AND ACCESS TO COMPANY In...

2008-07-03 09:01:19

RICHMOND, British Columbia, July 3, 2008 (PRIME NEWSWIRE) -- BioCurex Inc. (OTCBB:BOCX) is aware of the recent trading activity in the company's stock and notes that there has been no material change in the business of the Company to support this activity. The recent press releases document the significant progress that BioCurex is achieving both in the scientific arena and in the commercialization of its valuable technology. Thus, it is Management's opinion that the recent market activity...

2004-11-30 18:00:11

RICHMOND, British Columbia, Nov. 30, 2004 (PRIMEZONE) -- BioCurex Inc. (Pink Sheets:BOCX) BioCurex Inc. is pleased to report its findings on RECAF(tm) serum testing of Prostate cancer specimens. Our results show that BioCurex's RECAF serum test exhibited greater sensitivity and more importantly, much higher specificity than the currently used PSA test as shown in the table. TEST SENSITIVITY SPECIFICITY PSA (Prostate Specific Antigen) cutoff = 4 ng/ml...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related